MXEQX
Price
$29.98
Change
+$1.92 (+6.84%)
Updated
Apr 9 closing price
Net Assets
1.49B
RMEBX
Price
$53.86
Change
+$3.35 (+6.63%)
Updated
Apr 9 closing price
Net Assets
98.3B
Ad is loading...

MXEQX vs RMEBX

Header iconMXEQX vs RMEBX Comparison
Open Charts MXEQX vs RMEBXBanner chart's image
Empower Large Cap Value I
Price$29.98
Change+$1.92 (+6.84%)
VolumeN/A
Net Assets1.49B
American Funds American Mutual R2E
Price$53.86
Change+$3.35 (+6.63%)
VolumeN/A
Net Assets98.3B
MXEQX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXEQX vs. RMEBX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEQX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 98.3B vs. MXEQX (1.49B). RMEBX pays higher dividends than MXEQX: RMEBX (1.18) vs MXEQX (0.06). MXEQX was incepted earlier than RMEBX: MXEQX (30 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than MXEQX (0.98). RMEBX is a more actively managed with annual turnover of: 31.00 vs. MXEQX (29.00). MXEQX has a lower initial minimum investment than RMEBX: MXEQX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : -4.56 vs. MXEQX (-8.18). MXEQX return over 5 years is better than : 62.90 vs. RMEBX (44.36).
MXEQXRMEBXMXEQX / RMEBX
Total Expense Ratio0.961.0790%
Annual Report Gross Expense Ratio0.981.0792%
Fund Existence30 years11 years-
Gain YTD-9.014-7.747116%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B98.3B2%
Annual Yield % from dividends0.061.185%
Returns for 1 year-8.18-4.56180%
Returns for 3 years2.07-1.07-193%
Returns for 5 years62.9044.36142%
Returns for 10 years51.4444.99114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGHT2.350.26
+12.44%
Sight Sciences
REVG31.552.69
+9.32%
REV Group
CSGP78.735.50
+7.51%
CoStar Group
PFSI94.482.07
+2.24%
PennyMac Financial Services
BRNS0.69-0.03
-3.69%
Barinthus Biotherapeutics plc